Ketogenic diet therapies involve a collaborative healthcare team and therefore are typically offered in tertiary care centers. Centers that utilize these therapies with frequency gain valuable experience and become skilled in their practice. This chapter is a summary from the presentations of 5 practitioners including a nurse, pharmacist, and 3 dietitians who shared their expertise during the clinical session of the 2012 International Symposium.
WilderRM. The effects of ketonemia on the course of epilepsy. Mayo Clin Proc. 1921;2:307–308.
2.
HuttenlocherPRWilbourneAJSigmoreJM. Medium chain triglycerides as a therapy for intractable childhood epilepsy. Neurology. 1971;1:1097–1103.
3.
KossoffEHKraussGLMcGroganJRFreemanJM. Efficacy of the Atkins diet as therapy for intractable epilepsy. Neurology. 2003;61:1789–1791.
4.
KimYMVaidyaVVKhusainovT. Various indications for a modified Atkins diet in intractable childhood epilepsy. Brain Dev. 2012;34:570–575.
5.
MagrathGLeungMRandallT. The modified Atkins diet. In: NealEG, ed. Dietary Treatment of Epilepsy: Practical Implementation of Ketogenic Therapy. Oxford, UK: John Wiley & Sons; 2012.
6.
PfeiferHHThieleEA. Low-glycemic index treatment: a liberalized ketogenic diet for treatment of intractable epilepsy. Neurology. 2005;65:1810–1812.
7.
KossoffEHZupec-KaniaBAAmarkPE. Optimal clinical management of children receiving the ketogenic diet: recommendations of the international ketogenic diet study group. Epilepsia. 2009;50:304–317.
8.
BergqvistAGCSchallJIGallagherPRCnaanAStallingsVA. Fasting versus gradual initiation of the ketogenic diet: a randomised clinical trial of efficacy. Epilepsia. 2005;46:1810–1819.
9.
VaisleibIIBuchalterJRZupancML. Ketogenic diet: outpatient initiation, without fluid or caloric restrictions. Paediatr Neurol. 2004;31:198–202.
10.
RizzuttiSRamosAMFMuszkatMGabbaiAA. Is hospitalisation really necessary during the introduction of the ketogenic diet?J Child Neurol. 2007;22:33–37.
11.
LefevreFAronsonN. Ketogenic diet for the treatment of refractory epilepsy in children: a systematic review of efficacy. Pediatrics. 2000;105:E46.
12.
KeeneDL. A systematic review of the use of the ketogenic diet in childhood epilepsy. Paediatr Neurol. 2000;35:1–5.
13.
NealEGChaffeHMSchwartzR. The ketogenic diet in the treatment of epilepsy: a randomised controlled trial. Lancet Neurol. 2008;7:500–506.
14.
AuvinS. Should we routinely use modified Atkins diet instead of regular ketogenic diet to treat children with epilepsy?Seizure. 2012;21:237–240.
15.
MuzykewiczDALyczkowskiDAMemonNConantKDPfeiferHHThieleEA. Efficacy, safety, and tolerability of the low glycemic index treatment in pediatric epilepsy. Epilepsia. 2009;50:1118–1126.
16.
PortaNValléeLBoutryE. Comparison of seizure reduction and serum fatty acid levels after receiving the ketogenic and modified Atkins diet. Seizure. 2009;18:359–364.
17.
KossoffEHBosargeJLMirandaMJWiemer-KruelAKangHCKimHD. Will seizure control improve by switching from the modified Atkins diet to the traditional ketogenic diet?Epilepsia. 2010;51:2496–2499.
18.
KossoffEHTurnerZBlumlRMPyzikPLViningEP. A randomized, crossover comparison of daily carbohydrate limits using the modified Atkins diet. Epilepsy Behav. 2007;10:432–436.
19.
SeoJHLeeYMLeeJSKangHCKimHD. Efficacy and tolerability of the ketogenic diet according to lipid:nonlipid ratios—comparison of 3:1 with 4:1 diet. Epilepsia. 2007;48:801–805.
20.
RajuKNGulatiSKabraM. Efficacy of 4:1 (classic) versus 2.5:1 ketogenic ratio diets in refractory epilepsy in young children: a randomized open labeled study. Epilepsy Res. 2011;96:96–100.
21.
MirandaMJMortensenMPovlsenJHNielsenHBeniczkyS. Danish study of a modified Atkins diet for medically intractable epilepsy in children: can we achieve the same results as with the classical ketogenic diet?Seizure. 2011;20:151–155.
22.
NealEGChaffeHMSchwartzR. A randomized trial of classical and medium-chain triglyceride ketogenic diets in the treatment of childhood epilepsy. Epilepsia. 2008;49:1–9.
23.
KangHCChungDEKimDWKimHD. Early- and late-onset complications of the ketogenic diet for intractable epilepsy. Epilepsia. 2004;45:1116–1123.
24.
Berry-KravisEBoothGSanchezACWoodbury-KolbJ. Carnitine levels and the ketogenic diet. Epilepsia. 2001;42:1445–1451.
25.
KwiterovichPViningEPGPyzikPSkolaskyMAFreemanJM. Effect of a high fat ketogenic diet on plasma levels of lipids, lipoproteins, and apolipoproteins in children. J Am Med Assoc. 2003;290:912–919.
26.
ViningEPGPyzikPMcGroganJ. Growth of children on the ketogenic diet. Dev Med Child Neurol. 2002;44:796–802.
27.
SampathAKossoffEHFurthSLPyzikPLViningEPG. Kidney stones and the ketogenic diet: Risk factors and prevention. J Child Neurol. 2007;22:375–378.
28.
PaulEConantKDDunneIE. Urolithiasis on the ketogenic diet with concurrent topiramate or zonisamide therapy. Epilepsy Res. 2013;90:151–156.
29.
BergqvistAGSchallJIStallingsVA. Vitamin D status in children with intractable epilepsy, and impact of the ketogenic diet. Epilepsia. 2007;48:66–71.
30.
BergqvistAGSchallJIStallingsVAZemelBS. Progressive bone mineral content loss in children with intractable epilepsy treated with the ketogenic diet. Am J Clin Nutr. 2008;88:1678–1684.
31.
CoppolaGD'AnielloAMessanaT. Low glycemic index diet in children and young adults with refractory epilepsy: First Italian experience. Seizure. 2011;20:526–528.
32.
MirandaMJTurnerZMagrathG. Alternative diets to the classical ketogenic diet—Can we be more liberal?Epilepsy Res. 2012;100:278–285.
33.
SharmaSSankhyanNGulatiSAgarwalaA. Use of the modified Atkins diet in infantile spasms refractory to first-line treatment. Seizure. 2012;21:45–48.
34.
ItoYOguniHItoSOguniMOsawaM. A modified Atkins diet is promising as a treatment for glucose transporter type 1 deficiency syndrome. Dev Med Child Neurol. 2011;53:658–663.
35.
Zupec-KaniaBA. KetoCalculator: web-based program for calculating the ketogenic diet. https://www.ketocalculator.com. Accessed January 2012.
36.
TakeokaMRivielloJJPfeiferHThieleEA. Concomitant treatment with topiramate and ketogenic diet in pediatric epilepsy. Epilepsia. 2002;43:1072–1075.
37.
GroesbeckDKBlumRMKossoffEH. Long-term use of the ketogenic diet in the treatment of epilepsy. Dev Med Child Neurol. 2006;48:978–981.
38.
NordliDRJrKurodaMMCarrollJ. Experience with the ketogenic diet in infants. Pediatrics. 2001;108:129–133.
39.
KossoffEHPyzikPLMcGroganJRViningEPGFreemanJM. Efficacy of the ketogenic diet for infantile spasms. Pediatrics. 2002b;109:780–783.
40.
PellockJMHravchovyRShinnarSBarumTZInfantile Spasms: A U.S. consensus report. Epilepsia. 2010; 51:2175–2189.
41.
EunSHKangHCKimDWKimHD.Ketogenic diet for treatment of infantile spasms. Brain Dev. 200628:566–571.
42.
PiresMEIleaABourelE. Ketogenic diet for infantile spasms refractory to first line treatments: an open prospective study. Epilepsy Res. 2013; pii: S0920–1211(13)00013–2.
43.
HongAMTurnerZHamdyRFKossoffEH. Infantile spasms treated with the ketogenic diet: prospective single-center experience in 104 consecutive infants. Epilepsia. 2010;51:1403–1407.
44.
Zupec-KaniaBAAldazVMontgomeryMEKostasKC. Enteral and parenteral applications of ketogenic diet therapy: experience from four centers. ICAN. 2011;3:274.
45.
Jung daEKangHCLeeJSLeeEJKimHD. Safety and role of ketogenic parenteral nutrition for intractable childhood epilepsy. Brain Dev. 2012;34:620–624.
46.
RoanM. Management of long-term ketogenic parenteral nutrition. ICAN. 2011;3:282.
47.
WhelessJW. The Ketogenic diet. In: SwaimanKSAshwalS, eds. Pediatric Neurology: Principles and Practice. St. Louis, MO: Mosby; 1999:719–728.
BentleyDLifschitzCLawsonM.Enteral and parenteral nutrition. In: Pediatric Gastroenterology and Clinical Nutrition. London, UK: Remedica; 2001:37–45.
50.
PhillipsL. Parenteral fluids. In: AlexanderMCorriganAHankinsJGorskL, eds. Infusion Nursing: An Evidence-Based Approach. 3rd ed. St Louis, MO: Elsevier Health Sciences; 2010.
51.
KlepperJLeiendeckerB. GLUT1 deficiency syndrome—2007 update. Dev Med Child Neurol. 2007;49:707–716.
52.
WexlerIDHemalathaSGMcConnellJ. Outcome of pyruvate dehydrogenase deficiency treated with ketogenic diets. Studies in patients with identical mutations. Neurology. 1997;49:1655–1661.
53.
LiuYLiuFIqbalKGrundke-IqbalIGongCX. Decreased glucose transporters correlate to abnormal hyperphosphorylation of tau in Alzheimer disease. FEBS Lett. 2008;582:359–364.
54.
KangHCLeeYMKimHDLeeJSSlamaA. Safe and effective use of the ketogenic diet in children with epilepsy and mitochondrial respiratory chain complex defects. Epilepsia. 2007;48:82–88.
55.
JoshiCNGreenbergCRMhanniAASalmanMS. Ketogenic diet in Alpers-Huttenlocher syndrome. Pediatr Neurol. 2009;40:314–316.
56.
ValayannopoulosVBajolleFArnouxJBDuboisS. Successful treatment of severe cardiomyopathy in glycogen storage disease type III with d,l-3-hydroxybutyrate, ketogenic and high-protein diet. Pediatr Res. 2011;70:638–641.
57.
BuschVGempelKHackA. Treatment of glycogenosis type V with ketogenic diet. Ann Neurol. 2005;58:341.
58.
SwodobaJKSpechtLJonesHRShaprioFDi MauroSKorsonM. Infantile phosphofructokinase deficiency with arthrogryposis: clinical benefit of a ketogenic diet. J Pediatr. 1997;131:932–934.
59.
CusmaiRMartinelliDMoaveroR. Ketogenic diet in early myoclonic encephalopathy due to non ketotic hyperglycinemia. Eur J Paediatr Neurol. 2012;16:509–513.
60.
HedlundZNissesCZetterstromRH. Treatment of non-ketotic hyperglycinemia with ketogenic diet. International Symposium; Dietary therapies for epilepsy and other neurological disorders. Bloomingdale, IL. 2012: Abstract no. 26.
61.
DennyCAHeineckeKAKimYP. Restricted ketogenic diet enhances the therapeutic action of N-butyldeoxynojirimycin towards brain GM2 accumulation in adult Sandhoff disease mice. J Neurochem. 2010;113:1525–1535.
62.
SilvaMFAiresCCLuisPB. Valproic acid metabolism and its effects on mitochondrial fatty acid oxidation: a review. J Inherit Metab Dis. 2008;31:205–216.
63.
VerrottiAScaparrottaAAgostinelliSDi PilloSChiarelliFGrossoS. Topiramate-induced weight loss: a review. Epilepsy Res. 2011;95:189–199.
64.
WellmerJWellmerSBauerJ.The impact of zonisamide on weight. A clinical study in 103 patients with epilepsy. Acta Neurol Scand. 2009;119: 233–238.
65.
BergenDCRistanovicRKWaicoskyKKannerAHoeppnerTJ. Weight loss in patients taking felbamate. Clin Neuropharmacol. 1995;18:23–27.
66.
ChironCMarchandMCTranA. Stiripentol in severe myoclonic epilepsy in infancy: a randomised placebo-controlled syndrome-dedicated trial. STICLO study group. Lancet. 2000;356:1638–1642.
67.
DahlinMGBeckOMLAmarkPE. Plasma levels of antiepileptic drugs in children on the ketogenic diet. Pediatr Neurol. 2006;35:6–10.
68.
LyczkowskiDAPfeiferHHGhoshSThieleEA. Safety and tolerability of the ketogenic diet in paediatric epilepsy: effects of valproate combination therapy. Epilepsia. 2005;46:1533–1538.
69.
TakeokaMRivielloJPfeiferHThieleEA. Concomitant treatment with topiramate and ketogenic diet in pediatric epilepsy. Epilepsia. 2002;43:1072–1075.
70.
SumJMWochMAMcNeilT. Success and complications of the ketogenic diet for intractable childhood epilepsy. Epilepsia. 1996;37(suppl 5):10.
